Back
Celldex Therapeutics Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
33
CLDX
Celldex Therapeutics
Last Price:
25.37
Seasonality Move:
16.03%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing selling pressure, which indicates risk of future bearish movement.
Celldex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.08 | Sell |
| 20-day SMA: | 28.72 | Sell |
| 50-day SMA: | 34.94 | Sell |
| 200-day SMA: | 37.73 | Sell |
| 8-day EMA: | 26.96 | Sell |
| 20-day EMA: | 29.04 | Sell |
| 50-day EMA: | 32.54 | Sell |
| 200-day EMA: | 35.73 | Sell |
Celldex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.35 | Sell |
| Relative Strength Index (14 RSI): | 27.89 | Sell |
| Chaikin Money Flow: | -574428 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.31 - 31.51) | Sell |
| Bollinger Bands (100): | (30.97 - 40.49) | Sell |
Celldex Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 25.68 while CLDX 8-day simple moving average is 27.08, which is a Sell signal.
- The stock price of CLDX is 25.68 while Celldex Therapeutics 20-day SMA is 28.72, which makes it a Sell.
- Celldex Therapeutics 50-day simple moving average is 34.94 while CLDX share price is 25.68, making it a Sell technically.
- CLDX stock price is 25.68 and Celldex Therapeutics 200-day simple moving average is 37.73, creating a Sell signal.
CLDX Technical Analysis vs Fundamental Analysis
Sell
33
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a Sell
The current Celldex Therapeutics [CLDX] share price is $25.68. The Score for CLDX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
1.7B
Price in USD:
25.68
Share Volume:
1.13M
Celldex Therapeutics 52-Week Range
52-Week High:
53.18
52-Week Low:
24.72
Sell
33
Celldex Therapeutics (CLDX)
is a Sell
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?
The Celldex Therapeutics stock price is 25.68 USD today. -
Will CLDX stock go up or go down?
Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Celldex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is overvalued.
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 25.68 while CLDX 8-day exponential moving average is 26.96, which is a Sell signal.
- The stock price of CLDX is 25.68 while Celldex Therapeutics 20-day EMA is 29.04, which makes it a Sell.
- Celldex Therapeutics 50-day exponential moving average is 32.54 while CLDX share price is 25.68, making it a Sell technically.
- CLDX stock price is 25.68 and Celldex Therapeutics 200-day simple moving average is 35.73, creating a Sell signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and a decrease next year of $0.66 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
- CLDX Moving Average Covergence Divergence (MACD) indicator is -2.35, suggesting Celldex Therapeutics is a Sell
- Celldex Therapeutics Relative Strength Index (RSI) is 27.89, which suggest Celldex Therapeutics is oversold
- The Bollinger Bands (25) for Celldex Therapeutics is (27.31 - 31.51), which suggest Celldex Therapeutics is a Sell
- The Bollinger Bands (100) for Celldex Therapeutics is (30.97 - 40.49), which suggest Celldex Therapeutics is a Sell
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.